CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through YY1
Cancer Science · 2026-06 · 117 (6) · 1748-1765
DOI: 10.1111/cas.70377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 31.03.2026. Verfasst von Zihua Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Loudi Central Hospital, Loudi, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Glutamine, Amino Acid Transport System ASC, Thy-1 Antigens. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hunan Provincial Natural Science Foundation, National Natural Sciences Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
CD90 (THY1) is a cell surface glycoprotein that plays a crucial role in the occurrence and development of various malignant tumors. It affects tumor cell proliferation, metastasis, angiogenesis, stem cell characteristics, and energy metabolism. CD90 is an important biomarker for many malignant tumors and is closely related to tumor prognosis. However, the role and specific mechanisms of CD90 in glutamine metabolism in gastric cancer (GC) cells remain incompletely understood. In this study, we report that CD90 affects glutamine metabolism in GC cells through SLC1A5, ultimately promoting GC progression. Mechanistically, CD90 promotes the binding of YY1 to the SLC1A5 promoter, enhances the transcriptional activity of the SLC1A5 promoter, and increases its transcriptional level. This, in turn, affects SLC1A5‐mediated glutamine metabolism and ferroptosis in GC cells, ultimately facilitating GC progression. Our results suggest that CD90 plays an important role in regulating glutamine metabolism in GC cells, providing important experimental evidence for elucidating the pathogenesis of GC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Loudi Central Hospital, Loudi, China.
- Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China.
- Department of Early Clinical Trail Center, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
- Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
ORCID-Profile: Siyi Liu, Yanhong Zhou
Förderung
- Hunan Provincial Natural Science Foundation
- National Natural Sciences Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhou, Z., Liu, S., Zhang, C., Deng, J., Liang, L., & Zhou, Y. (2026). CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through YY1. Cancer Science, 117(6), 1748-1765. https://doi.org/10.1111/cas.70377
Vancouver
Zhou Z, Liu S, Zhang C, Deng J, Liang L, Zhou Y. CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through YY1. Cancer Science. 2026;117(6):1748-1765. doi:10.1111/cas.70377
BibTeX
@article{Zhou2026,
author = {Zhou, Zihua and Liu, Siyi and Zhang, Chenyu and Deng, Jun and Liang, Lin and Zhou, Yanhong},
title = {CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5 ‐Mediated Glutamine Metabolism Through YY1},
journal = {Cancer Science},
year = {2026},
volume = {117},
number = {6},
pages = {1748--1765},
doi = {10.1111/cas.70377}
}
EUVIMED